Sort   by:  
 Page size 
UnknownDonor-Related Risk Factors for Normothermic Machine Perfusion in Liver Transplantation: A Meta-Analysis.
Not available
S-EPMC12039471 | biostudies-literature
UnknownThe immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer.
Not available
S-EPMC10603010 | biostudies-literature
UnknownOptimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort.
Not available
S-EPMC10264658 | biostudies-literature
UnknownFOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium.
Not available
S-EPMC9086789 | biostudies-literature
UnknownNeoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.
Not available
S-EPMC9326480 | biostudies-literature
UnknownStereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design.
Not available
S-EPMC9801528 | biostudies-literature
UnknownIntraoperative Ultrasound During Surgical Exploration in Patients with Pancreatic Cancer and Vascular Involvement (ULTRAPANC): A Prospective Multicenter Study.
Not available
S-EPMC10175412 | biostudies-literature
UnknownPredictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
Not available
S-EPMC10480034 | biostudies-literature
Sort   by:  
 Page size